Sézary Syndrome Biomarker, T Cell Transcription Factors and Cytokine Genes Provide Novel Insight into Response During Mogamulizumab Treatment

Alanna Davis, Jun Ying, Ping-Ching Hsu, Jeffrey Chen, Khiem Tran, Henry K. Wong

Open source

DOI
10.3390/cancers18142304
Published
2026-07-17
Container
Cancers
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18142304,
  title = {Sézary Syndrome Biomarker, T Cell Transcription Factors and Cytokine Genes Provide Novel Insight into Response During Mogamulizumab Treatment},
  author = {Alanna Davis and Jun Ying and Ping-Ching Hsu and Jeffrey Chen and Khiem Tran and Henry K. Wong},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18142304},
  url = {https://doi.org/10.3390/cancers18142304}
}

RIS

TY  - JOUR
TI  - Sézary Syndrome Biomarker, T Cell Transcription Factors and Cytokine Genes Provide Novel Insight into Response During Mogamulizumab Treatment
AU  - Alanna Davis
AU  - Jun Ying
AU  - Ping-Ching Hsu
AU  - Jeffrey Chen
AU  - Khiem Tran
AU  - Henry K. Wong
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18142304
UR  - https://doi.org/10.3390/cancers18142304
ER  - 

APA

Davis, A., Ying, J., Hsu, P., Chen, J., Tran, K., & Wong, H. K. (2026). Sézary Syndrome Biomarker, T Cell Transcription Factors and Cytokine Genes Provide Novel Insight into Response During Mogamulizumab Treatment. Cancers. https://doi.org/10.3390/cancers18142304

Source records